Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
369K
-
Shares change
-
+214K
-
Total reported value, excl. options
-
$855K
-
Value change
-
+$408K
-
Number of buys
-
9
-
Number of sells
-
-4
-
Price
-
$2.32
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q4 2021
14 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q4 2021.
HCW Biologics Inc. - COM (HCWB) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 369K shares
.
Largest 10 shareholders include TWO SIGMA INVESTMENTS, LP (125K shares), VANGUARD GROUP INC (82.5K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (46.6K shares), GEODE CAPITAL MANAGEMENT, LLC (42.5K shares), STATE STREET CORP (20.1K shares), BlackRock Inc. (16.7K shares), Cresset Asset Management, LLC (12.5K shares), RENAISSANCE TECHNOLOGIES LLC (11.9K shares), HighTower Advisors, LLC (10K shares), and Focused Wealth Management, Inc (1K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.